NeuroOne stock is down on Q4 revenue misses
NeuroOne Medical Technologies (Nasdaq:NMTC) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast.
Stay updated with breaking news from Rosa One Brain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NeuroOne Medical Technologies (Nasdaq:NMTC) shares took a hit today on fourth-quarter results that fell shy of the consensus sales forecast.
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it priced an underwritten registered public offering.
NeuroOne Medical Technologies (Nasdaq:NMTC) today announced the first clinical case performed with its Evo sEEG in robotic neurosurgery.
NeuroOne Medical Technologies (Nasdaq:NMTC) announced today that it commercially launched its Evo sEEG electrode line in the U.S.
NeuroOne won expanded FDA clearance for use of its Evo sEEG Electrode technology with brain recording, monitoring and stimulation equipment.